SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001561743-19-000053
Filing Date
2019-08-01
Accepted
2019-08-01 16:06:34
Documents
59
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kindred10qq22019.htm 10-Q 979039
2 EXHIBIT 31.1 exhibit311q22019.htm EX-31.1 14029
3 EXHIBIT 31.2 exhibit312q22019.htm EX-31.2 14048
4 EXHIBIT 32.1 exhibit321q22019.htm EX-32.1 8141
  Complete submission text file 0001561743-19-000053.txt   6193904

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kin-20190630.xml EX-101.INS 1617196
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20190630.xsd EX-101.SCH 35279
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20190630_cal.xml EX-101.CAL 65933
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20190630_def.xml EX-101.DEF 170917
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20190630_lab.xml EX-101.LAB 519824
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20190630_pre.xml EX-101.PRE 312230
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36225 | Film No.: 19992692
SIC: 2834 Pharmaceutical Preparations